Cargando…
Transporting carriers for intracellular targeting delivery via non-endocytic uptake pathways
To develop novel therapies for clinical treatments, it increasingly depends on sophisticated delivery systems that facilitate the drugs entry into targeting cells. Profound understanding of cellular uptake routes for transporting carriers promotes the optimization of performance in drug delivery sys...
Autores principales: | Li, Zuhong, Zhang, Yanhong, Zhu, Danhua, Li, Shuiqing, Yu, Xiaopeng, Zhao, Yalei, Ouyang, Xiaoxi, Xie, Zhongyang, Li, Lanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812582/ https://www.ncbi.nlm.nih.gov/pubmed/29069996 http://dx.doi.org/10.1080/10717544.2017.1391889 |
Ejemplares similares
-
Recent Advances in Nanomaterials-Based Chemo-Photothermal Combination Therapy for Improving Cancer Treatment
por: Li, Zuhong, et al.
Publicado: (2019) -
ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
por: Ouyang, Xiaoxi, et al.
Publicado: (2022) -
Comprehensive analysis of ubiquitin‐specific protease 1 reveals its importance in hepatocellular carcinoma
por: Zhao, Yalei, et al.
Publicado: (2020) -
A promising new cancer marker: Long noncoding RNA EGFR-AS1
por: Zhu, Danhua, et al.
Publicado: (2023) -
Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/mitogen‐activated protein kinase and TLR4/nuclear factor‐κB pathways and autophagy
por: Zhang, Lingjian, et al.
Publicado: (2019)